SCHEMBL97542

SCHEMBL97542

CCC(C)c1cccc(O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.62
HDAC2 Q92769 1/20 0.62
HDAC8 Q9BY41 1/20 0.62
ALDH1A1 P00352 3/20 0.56
GAA P10253 2/20 0.56
HSD17B10 Q99714 2/20 0.56
USP2 O75604 1/20 0.56
PKM P14618 1/20 0.56
HPGD P15428 1/20 0.56
ALOX15 P16050 1/20 0.56
SLC22A1 O15245 1/20 0.56
OPRM1 P35372 1/20 0.56
ADRB1 P08588 2/20 0.53
ADRA1A P35348 2/20 0.53
MIF P14174 1/20 0.53
HTR2A P28223 1/20 0.53
HTR2B P41595 1/20 0.53
HIF1A Q16665 4/20 0.51
LMNA P02545 4/20 0.51
GALR3 O60755 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17399704 1.00 HDAC4 (0.62) HDAC4HDAC2HDAC8ALDH1A1GAA
Butane SCHEMBL28745339 0.96 HDAC4 (0.59) HDAC4HDAC2HDAC8ALDH1A1GAA
Phenol SCHEMBL28146813 0.88 HDAC4 (0.59) HDAC4HDAC2HDAC8ALDH1A1GAA
SCHEMBL1006801 0.84 HDAC4 (0.62) HDAC4HDAC2HDAC8ALDH1A1GAA
SCHEMBL6912280 0.84 ADRB1 (0.50) HDAC4HDAC2HDAC8ALDH1A1GAA
SCHEMBL20738464 0.83 ADRB1 (0.53) HDAC4HDAC2HDAC8ALDH1A1GAA
SCHEMBL9169343 0.83 ADRB1 (0.53) HDAC4HDAC2HDAC8ALDH1A1GAA
Phenol SCHEMBL28108617 0.82 HDAC4 (0.53) HDAC4HDAC2HDAC8ALDH1A1GAA
SCHEMBL632781 0.82 TAAR1 (0.57) HDAC4HDAC2HDAC8ALDH1A1GAA
SCHEMBL15427747 0.82 ADRB1 (0.52) HDAC4HDAC2HDAC8ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1034 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970083-B1 PROCESS TO PREPARE LEVULINIC ACID GFBIOCHEMICALS IP ASSETS B V (NL) 2021-10-20 EP claimed
US-20170190651-A1 PROCESS TO PREPARE LEVULINIC ACID GFBIOCHEMICALS LTD (MT) 2017-07-06 US claimed
US-9598341-B2 Process to prepare levulinic acid GFBIOCHEMICALS LIMITED (MT) 2017-03-21 US claimed
EP-2970083-A1 PROCESS TO PREPARE LEVULINIC ACID Segetis, Inc. (US) 2016-01-20 EP claimed
CN-105209421-A Process to prepare levulinic acid SEGETIS INC 2015-12-30 CN claimed
US-20150291499-A1 PROCESS TO PREPARE LEVULINIC ACID GFBIOCHEMICALS LIMITED (MT) 2015-10-15 US claimed
US-9073841-B2 Process to prepare levulinic acid SEGETIS, INC. (US) 2015-07-07 US claimed
WO-2014159992-A1 PROCESS TO PREPARE LEVULINIC ACID SEGETIS, INC. (US) 2014-10-02 WO claimed
US-20140128634-A1 PROCESS TO PREPARE LEVULINIC ACID GFBIOCHEMICALS LIMITED (MT) 2014-05-08 US claimed
EP-1103566-A1 Nickel-based catalyst and gas phase polymerization process for polybutadiene UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2001-05-30 EP claimed
CN-1296984-A Nickel-based catalyst for producing polybutadiene and gas-phase polymerization process thereof UNION CARBIDE CHEM PLASTIC (US) 2001-05-30 CN claimed
US-5663265-A FREE RADICAL COPOLYMERIZATION FOR COATINGS HOECHST AKTIENGESELLSCHAFT (DE) 1997-09-02 US claimed
JP-59078105-A None JP disclosed
US-20250188066-A1 ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2025-06-12 US disclosed
CN-120118458-A Curable composition, resin, and cured product 东京应化工业株式会社 2025-06-10 CN disclosed
CN-119937242-A Photosensitive resin composition 东京应化工业株式会社 2025-05-06 CN disclosed
US-4131584-A M-AMINOPHENOL MARION DARRAH AND JOSEPH Y. HOUGHTON, CO-TRUSTEES (US) 1978-12-26 US disclosed
US-3962491-A Process for producing resin-coated sand particles for use in shell moles AISIN CHEMICAL COMPANY, LIMITED (JA) 1976-06-08 US disclosed
US-3944703-A Fibrous batts impregnated with aqueous dispersions based on heat-hardenable phenolic resins UNION CARBIDE CORPORATION (US) 1976-03-16 US disclosed
US-3936473-A COPPER OR NOBLE METAL SALT, OXYGEN AND ORGANIC ACID CATALYST UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250188066-A1 ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS IRF3, EIF2AK2, ZC3HAV1 HDAC4 1949/4885HDAC2 921/4885HDAC8 1317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.